BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 2300666)

  • 1. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
    Otake M; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of gamma and neutron radiation to posterior lenticular opacities among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M; Schull WJ
    Radiat Res; 1982 Dec; 92(3):574-95. PubMed ID: 7178422
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cataract in atomic bomb survivors based on a threshold model and the occurrence of severe epilation.
    Otake M; Neriishi K; Schull WJ
    Radiat Res; 1996 Sep; 146(3):339-48. PubMed ID: 8752314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-related ophthalmological changes and aging among Hiroshima and Nagasaki A-bomb survivors: a reanalysis.
    Otake M; Finch SC; Choshi K; Takaku I; Mishima H; Takase T
    Radiat Res; 1992 Sep; 131(3):315-24. PubMed ID: 1438690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation.
    Stram DO; Mizuno S
    Radiat Res; 1989 Jan; 117(1):93-113. PubMed ID: 2913611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
    Brenner DJ
    Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
    Hunter N; Charles MW
    J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
    Gilbert ES; Ohara JL
    Radiat Res; 1984 Oct; 100(1):124-38. PubMed ID: 6494426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrons confirmed in Nagasaki and at the Army Pulsed Radiation Facility: implications for Hiroshima.
    Straume T; Harris LJ; Marchetti AA; Egbert SD
    Radiat Res; 1994 May; 138(2):193-200. PubMed ID: 8183989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 17. Congenital malformations, stillbirths, and early mortality among the children of atomic bomb survivors: a reanalysis.
    Otake M; Schull WJ; Neel JV
    Radiat Res; 1990 Apr; 122(1):1-11. PubMed ID: 2320718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
    Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
    Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
    Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
    J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermoluminescence dosimetry of gamma rays using ceramic samples from Hiroshima and Nagasaki: a comparison with DS86 estimates.
    Nagatomo T; Ichikawa Y; Hoshi M
    J Radiat Res; 1991 Mar; 32 Suppl():48-57. PubMed ID: 1762131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.